360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

Pharmascience

Image source: Freebase

Type: Company

Name: Pharmascience

First reported Jun 05 2013 - Updated Jun 05 2013 - 1 reports

Oxford Pharmascience says Brazilian partner to launch new product

We are a specialist pharmaceutical technology company developing and licensing solutions to add value to off patent and soon to be off patent drugs. Our technology portfolio includes delivery systems for liquid suspensions, solid state suspensions (soft ... [Published Proactive Investors USA - Jun 05 2013]

Entities: Pharmascience, Calcium, Share Price, Vitamin D

First reported Jun 05 2013 - Updated Jun 05 2013 - 1 reports

Firms shortlisted in top healthcare awards...

FOUR Derbyshire firms have been shortlisted for regional awards which recognise achievement in the healthcare, bioscience and medical sectors.Quadralene, in Derby; Oxford Pharmascience Group, in Chellaston; Francis Lamont Innovations, in Hathersage; and ... [Published Derby Telegraph - Jun 05 2013]

Entities: Pharmascience, Health Care, Darren Clark

First reported Jun 04 2013 - Updated Jun 05 2013 - 2 reports

Pharmascience

Oxford Pharmascience Group Plc Given Corporate Rating at N+1 Singer (OXP)

Oxford Pharmascience Group Plc (LON: OXP) Oxford Pharmascience Group Plc (LON: OXP) traded down 0.42% on Tuesday, hitting GBX 4.1075. Oxford Pharmascience Group Plc has a 52-week low of GBX 0.857 and a 52-week high of GBX 4.30. The stock?s 50-day moving ... [Published American Banking News - Jun 05 2013]

Entities: Pharmascience, Vitamin, Moving Average

First reported Jun 04 2013 - Updated Jun 04 2013 - 4 reports

Andor Technology

FTSE 100 fights back on ‘Turnaround Tuesday’

The UK’s blue chips began the comeback from four-week lows on a day that is becoming known on Wall Street as ‘Turnaround Tuesday’. America’s mysterious infatuation with Tuesday trading continues as the Dow Jones is eyeing finishing in the black on Tuesday ... [Published Proactiveinvestors United Kingdom website - Jun 04 2013]

Entities: FTSE 100, Andor Technology, Enegi Oil Plc, Baobab Resources plc

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Eurasian Natural Resources Corporation

Broker Round-up II: Nyota Minerals, Enegi Oil, Goldplat, Oxford Pharmascience

The optimisation of Nyota Minerals ’ ( LON:NYO , ASX:NYO) flagship Tulu Kapi project in Ethiopia is a good step forward for the company. That’s the view of Investec , which was one of a number of brokers to welcome today’s update from the gold explorer. ... [Published Proactiveinvestors United Kingdom RSS feed - Jun 04 2013]

Entities: Pharmascience, Eurasian Natural Resources Corporation, Enegi Oil Plc, Nyota Minerals

First reported Jun 04 2013 - Updated Jun 04 2013 - 2 reports

Oxford Pharmascience says Brazilian partner to launch new product

--Adds share price reaction and broker comment-- Oxford Pharmascience ( LON:OXP ), which specialises in reformulating tried and tested medicines, has agreed a line extension in Brazil with its Brazilian partner Aché Pharmaceuticos. The deal is ... [Published Proactiveinvestors United Kingdom RSS feed - Jun 04 2013]

Entities: Pharmascience, Calcium, Share Price, Vitamin D

First reported Jun 04 2013 - Updated Jun 04 2013 - 1 reports

Oxford Pharmascience : Ache Line Extension

Oxford Pharmascience Group plc("Oxford Pharmascience" or "the Company") Oxford Pharmascience announces line extension for Brazil Oxford Pharmascience, the specialty pharmaceutical company that uses advanced pharmaceutic technologies to make medicines ... [Published Investegate - Jun 04 2013]

Entities: Pharmascience, Brazil, Drugs

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Why the lure of Latin America is proving so tempting for our businesses

Latin America is a land of opportunity for our companies, according to senior Foreign Office figures. Oliver Astley reports.THE buzz about doing business in Brazil was palpable in Derby last week as the visiting UK ambassador to the South American ... [Published Derby Telegraph - May 22 2013]

Entities: Alan Charlton, Colombia, Brazil, United Kingdom

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Oxford Pharma brings new life to tried and tested drugs

Marcelo Bravo, Chief Technology Officer at Oxford Pharmascience ( LON:OXP ), explains to Proactiveinvestors how the company re-engineers existing drugs to improve the way they work and overcome side effects. Marcelo discusses the recent successful ... [Published Proactiveinvestors United Kingdom RSS feed - May 22 2013]

Entities: Drugs, Pharmascience, nonsteroidal anti-inflammatory drug

First reported May 09 2013 - Updated May 09 2013 - 2 reports

Oxford Pharmascience shares advance further on ibuprofen data

Shares in Oxford Pharmascience ( LON:OXP ) advanced a further 2% and built on Wednesday’s gains as the market continued to digest data on its safer iteration of a top selling painkiller. OXP’s study indicated its OXPzero Ibuprofen could reduce stomach ... [Published Proactiveinvestors United Kingdom RSS feed - May 09 2013]

Entities: Pharmascience, Ibuprofen, Stocks, Sheena Berry

First reported May 08 2013 - Updated May 08 2013 - 2 reports

Manchester United shares fall on Ferguson retirement; Wall Street opens mixed

Shares in the prolific football club Manchester United ( NYSE:MANU ) dropped as trading started in New York after news that legendary manager Sir Alex Ferguson is to retire. Arguably the greatest manager English football has ever seen, the news has ... [Published Proactiveinvestors United Kingdom RSS feed - May 08 2013]

Entities: Sir Alex Ferguson, Iron Ore, Wall Street, NSAIDs

First reported Mar 20 2013 - Updated Mar 20 2013 - 2 reports

Oxford Pharmascience enjoys bounce from Brazil

Eye-catching top line growth fed through to a sharp reduction in losses in 2012 at drugs developer Oxford Pharmascience ( LON:OXP ). Results for the year were ahead of expectations, with revenue up 65% to £466,000 from £282,000 the year before, thanks ... [Published Proactiveinvestors United Kingdom website - Mar 20 2013]

Entities: Pharmascience, Brazil, David Norwood, Taxes, NSAIDs

Quotes

Company founder Malcolm Wootton said: "I hope that, with the continued support of Medilink and some action from the local Academic Health Science Network, this will help to raise our UK profile to the levels we have achieved overseas in the past 18 months."

Award-winners are 'making a difference' to healthcare all... [Published Derby Telegraph - Jun 19 2013]

"Our chew business in Brazil continues to grow strongly and the addition of a new version of our calcium product in the Brazilian market shows both the commitment of our partner and the ongoing potential for the range,” said Nigel Theobald, chief executive officer of Oxford Pharmascience."

Oxford Pharmascience says Brazilian partner to launch new product [Published Proactive Investors USA - Jun 05 2013]

Medilink's Dr Darren Clark said: "These companies are proof that innovative ideas and manufacturing are thriving in this part of the region."

Firms shortlisted in top healthcare awards... [Published Derby Telegraph - Jun 05 2013]

"A break of 6,500 could see another 100 point decline which looks nasty, but the long-term graph shows just how far the index has rallied/recovered and how this move wouldn’t in fact be excessive" he notes this morning

FTSE 100 climbs as investors buoyed by economic data [Published Proactive Investors.co.uk - Jun 04 2013]

More Content

sort by: Date \| Relevance
Award-winners are 'making a difference' to h... [Published Derby Telegraph - Jun 19 2013]
Oxford Pharmascience says Brazilian partner to ... [Published Proactive Investors USA - Jun 05 2013]
Firms shortlisted in top healthcare awards... [Published Derby Telegraph - Jun 05 2013]
Oxford Pharmascience Group Plc Given Corporate ... [Published American Banking News - Jun 05 2013]
FTSE 100 fights back on ‘Turnaround Tuesday’ [Published Proactiveinvestors United Kingdom website - Jun 04 2013]
Dow Jones continues Tuesday love affair [Published Proactive Investors.co.uk - Jun 04 2013]
Dow Jones continues Tuesday love affair [Published Proactiveinvestors United Kingdom RSS feed - Jun 04 2013]
FTSE 100 climbs as investors buoyed by economic... [Published Proactive Investors.co.uk - Jun 04 2013]
Broker Round-up II: Nyota Minerals, Enegi Oil, ... [Published Proactiveinvestors United Kingdom RSS feed - Jun 04 2013]
Oxford Pharmascience says Brazilian partner to ... [Published Proactiveinvestors United Kingdom RSS feed - Jun 04 2013]
Oxford Pharmascience Group Plc Rating Reiterate... [Published The Utah People's Post - Jun 04 2013]
Oxford Pharmascience says new Inellare line to ... [Published Proactive Investors.co.uk - Jun 04 2013]
Oxford Pharmascience : Ache Line Extension [Published Investegate - Jun 04 2013]
BELLUS Health Inc (BLU) - Financial and Strateg... [Published TransWorldNews - Jun 02 2013]
Oxford Pharma brings new life to tried and test... [Published Proactiveinvestors United Kingdom RSS feed - May 22 2013]
Why the lure of Latin America is proving so tem... [Published Derby Telegraph - May 22 2013]
Broker Round-up part 2: Oxford Pharmascience, G... [Published Proactiveinvestors United Kingdom RSS feed - May 15 2013]
Oxford Pharmascience price target raised 33% by... [Published Proactiveinvestors United Kingdom RSS feed - May 15 2013]
Proactive Investors Mid & Sml Cap Weekly Roundu... [Published Proactiveinvestors United Kingdom RSS feed - May 11 2013]
Oxford Pharmascience shares advance further on ... [Published Proactiveinvestors United Kingdom RSS feed - May 09 2013]
Oxford Pharmascience shares advance a further o... [Published Proactiveinvestors United Kingdom RSS feed - May 09 2013]
Proactive news summary including IMIC, Providen... [Published Proactiveinvestors United Kingdom RSS feed - May 08 2013]
Oxford Pharmascience to develop range of safer ... [Published Proactiveinvestors United Kingdom RSS feed - May 08 2013]
Manchester United shares fall on Ferguson retir... [Published Proactiveinvestors United Kingdom RSS feed - May 08 2013]
FTSE 100 edges higher despite disappointing upd... [Published Proactiveinvestors United Kingdom RSS feed - May 08 2013]
Big Pharma's patent cliff offers opportunities ... [Published Proactiveinvestors United Kingdom RSS feed - Apr 17 2013]
Oxford Pharmascience enjoys bounce from Brazil [Published Proactiveinvestors United Kingdom website - Mar 20 2013]
Final Results [Published TrustNet - Mar 20 2013]
Tuesday's agenda: Sainsbury looking for Red Nos... [Published Proactiveinvestors United Kingdom RSS feed - Mar 18 2013]
Week ahead: Osborne to keep singing same old song [Published Proactiveinvestors United Kingdom RSS feed - Mar 17 2013]

Blogs

sort by: Date \| Relevance
FTSE 100 fights back on ‘Turnaround Tuesday’ [Published Proactiveinvestors United Kingdom website - Jun 04 2013] The UK’s blue chips began the comeback from four-week lows on a day that is becoming known on Wall Street as ‘Turnaround Tuesday’. America’s mysterious infatuation with Tuesday trading continues as the Dow Jones is eyeing finishing in the black on Tuesday ...
Oxford Pharmascience enjoys bounce from Brazil [Published Proactiveinvestors United Kingdom website - Mar 20 2013] Eye-catching top line growth fed through to a sharp reduction in losses in 2012 at drugs developer Oxford Pharmascience ( LON:OXP ). Results for the year were ahead of expectations, with revenue up 65% to £466,000 from £282,000 the year before, thanks ...
Oxford Pharmascience gets heavyweight backing t... [Published Proactiveinvestors United Kingdom website - Feb 27 2013] Oxford Pharmascience ( LON:OXP ) has brought on board a new major new shareholder though a fund raise to accelerate its growth plans. Invesco Asset Management and its funds have taken up 166.7 mln new shares at 3p that will raise £5mln for the ...
Wall Street bounces back [Published Proactiveinvestors United Kingdom website - Feb 22 2013] US stocks got battered again yesterday but finished off their lows, and that rally has been continued this morning with the major benchmarks advancing. Investors had been spooked by the prospect of the Fed turning off the quantitative easing tap, plus ...
Broker Round-up part 2, including Fox Marble, B... [Published Proactiveinvestors United Kingdom website - Jan 28 2013] Fox Marble ( LON:FOX ) was on the receiving end of an upgrade to ‘buy’ from small cap broker Fox-Davies. It comes after the authorities in Kosovo restored four quarry licences annulled last month. A fifth, covering the producing Cervenilla quarry, ...

Press Releases

sort by: Date \| Relevance
Helix Announces Completion of the Sale of Its R... [Published Marketwire - Breaking News Releases - Jan 25 2013]
Helix Announces Shareholder Approval for the Sa... [Published Marketwire - Breaking News Releases - Jan 24 2013]
Montreal's Pharmascience Inc. donates vitally n... [Published PR Newswire - Sep 25 2012]